Latvia: cancer treatment funding second lowest in Europe
Over the course of two years, Latvia’s list of state-compensated medicines has been expanded with only two modern generation medicines for cancer treatment, which is less when compared to Lithuania and Estonia, as reported by Association of International Innovative Pharmaceuticals Producers (SIFFA) director Valters Bolevics. In Latvia the two latest additions to the list of…